Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Arcadia Biosciences Q2 EPS $0.61 Beats $(4.80) Estimate, Sales $1.39M Miss $1.82M Estimate

Author: Benzinga Newsdesk | August 10, 2023 05:04pm
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $(4.80) by 112.71 percent. This is a 108.97 percent increase over losses of $(6.80) per share from the same period last year. The company reported quarterly sales of $1.39 million which missed the analyst consensus estimate of $1.82 million by 23.68 percent. This is a 64.00 percent decrease over sales of $3.86 million the same period last year.

Posted In: RKDA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist